The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 25, 2020

Filed:

Jan. 03, 2017
Applicant:

Je Ii Pharmaceutical Co., Ltd., Seoul, KR;

Inventors:

Joon Woo Nam, Seongnam-si, KR;

Jong Yup Kim, Yongin-si, KR;

Kyung Hoon Kim, Yongin-si, KR;

Jung Mee Lee, Yongin-si, KR;

Ji Yoon Kim, Yongin-si, KR;

Ji Seon Park, Yongin-si, KR;

Joseph Kim, Yongin-si, KR;

Yoon Sun Park, Yongin-si, KR;

Jeong Min Kim, Seongnam-si, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 15/203 (2006.01); C07H 7/04 (2006.01); C07D 309/10 (2006.01); A61K 31/7034 (2006.01); A61P 3/10 (2006.01);
U.S. Cl.
CPC ...
C07D 309/10 (2013.01); A61K 31/7034 (2013.01); A61P 3/10 (2018.01); C07H 7/04 (2013.01); C07H 15/203 (2013.01); Y02P 20/55 (2015.11);
Abstract

The present disclosure relates to C-glycoside derivatives having a fused phenyl ring or pharmaceutical acceptable salts thereof, a method for preparing the same, a pharmaceutical composition comprising the same, a use thereof and a method for dual inhibition of SGLT1 and SGLT2 using the same. A novel compound of the present disclosure has a dual inhibitory activity against SGLT1 and SGLT2, thus being valuably used as a diabetes therapeutic agent.


Find Patent Forward Citations

Loading…